Company
Headquarters: Rome, RM, Italy
Employees: 1,187
CEO: Ms. Maria Laura Garofalo
€449.5 Million
EUR as of Jan. 1, 2025
US$467.7 Million
Company | Market Cap (USD) |
---|---|
Lilly | $689.42 B |
Novo Nordisk | $622.07 B |
UnitedHealth Group | $487.54 B |
Johnson & Johnson | $353.05 B |
AbbVie | $301.60 B |
Garofalo Health Care S.p.A. operates healthcare centers in Italy. It offers services in the areas of high-complexity surgery, medium- and low-complexity surgery, emergency surgery, medicine, clinical and interventional cardiology, and extended and intensive care units, as well as motor, neurological, cardiac, and nutritional rehabilitation. The company also operates centers for patients in coma and persistent vegetative states; and psychiatric and diagnostic centers. It operates 19 healthcare facilities located in Piedmont, Veneto, Tuscany, Emilia-Romagna, Lazio, and Liguria. The company is based in Rome, Italy.
Garofalo Health Care SpA has the following listings and related stock indices.
Stock: FSX: GHC wb_incandescent